Concord Biotech Limited — Dividend/Bonus, 29-05-2026: Dividend

Concord Biotech's Board has put forward a final dividend of ₹7.55 per equity share (face value ₹1) for the fiscal year 2025-26. This payout, marking the year's closing distribution, awaits shareholder approval at the Annual General Meeting. The company has set July 24, 2026, as the record date to determine eligible shareholders. Get ready to capture this potential return!